OVATF
Ovation Science Inc.
Price Chart
Latest Quote
$0.04
+0.00 (+0.00%)
Current Price
| Previous Close | $0.04 |
| Open | $0.04 |
| Day High | $0.04 |
| Day Low | $0.04 |
| Volume | 20,000 |
Stock Information
Note: Financial values converted from CAD to USD
| Shares Outstanding | 38.41M |
| Total Debt | $203K |
| Cash Equivalents | $28K |
| Revenue | $46K |
| Net Income | $-435K |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | $1.34M |
| EPS (TTM) | $-0.01 |
| Exchange | PNK |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $1.59M |
| Sales | $46K |
| Income | $-435K |
| Book/sh | $-0.03 |
| Cash/sh | $0.00 |
Financial Ratios
| Quick Ratio | 0.03 |
| Current Ratio | 0.03 |
Returns & Margins
| ROA | -766.07% |
| Gross Margin | 57.88% |
| Operating Margin | -632.13% |
Ownership
| Insider Ownership | 23.46% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 20.43 |
| P/B | -1.19 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.04 |
| SMA50 | $0.04 |
| SMA200 | $0.03 |
| RSI | nan |
| Shares Float | 29.40M |
| Volatility | 0.69 |
Performance History
| Week | +0.00% |
| Month | +0.00% |
| Quarter | +65.09% |
| 6 Months | +18.64% |
| YTD | +18.64% |
| Year | -27.39% |
| 3 Years | +1421.74% |
| 5 Years | -77.35% |
| 10 Years | -87.57% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $0.04 | 0 |
| 2026-06-17 | $0.04 | 0 |
| 2026-06-16 | $0.04 | 0 |
| 2026-06-15 | $0.04 | 0 |
| 2026-06-12 | $0.04 | 0 |
| 2026-06-11 | $0.04 | 0 |
| 2026-06-10 | $0.04 | 0 |
| 2026-06-09 | $0.04 | 0 |
| 2026-06-08 | $0.04 | 0 |
| 2026-06-05 | $0.04 | 0 |
| 2026-06-04 | $0.04 | 0 |
| 2026-06-03 | $0.04 | 0 |
| 2026-06-02 | $0.04 | 0 |
| 2026-06-01 | $0.04 | 0 |
| 2026-05-29 | $0.04 | 0 |
| 2026-05-28 | $0.04 | 0 |
| 2026-05-27 | $0.04 | 0 |
| 2026-05-26 | $0.04 | 0 |
| 2026-05-22 | $0.04 | 0 |
| 2026-05-21 | $0.04 | 0 |
| 2026-05-20 | $0.04 | 0 |
| 2026-05-19 | $0.04 | 0 |
About Ovation Science Inc.
Ovation Science Inc. engages in the production, sub-licensing, and sale of cannabis or hemp products in the United States. The company's patented skin delivery technology Invisicare, a patented polymer-based technology for topical and transdermal skin care products under the Ovation brand name. It also offers cannabis health and wellness products under the Invibe MD name; anti-aging products under the ARLO CBD name; and topical and transdermal creams and lotions with CBD, THC, and combinations, as well as hemp seed oil. The company was incorporated in 2017 and is headquartered in Vancouver, Canada. Ovation Science Inc. operates as a subsidiary of Skinvisible Pharmaceuticals, Inc.
đ° Latest News
No news articles available at the moment. Check back later for updates on OVATF.
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $27,497 | $7,834 | $2,976 | $36,954 |
| Cost Of Revenue | $27,497 | $7,834 | $2,976 | $36,954 |
| Total Revenue | $113,215 | $61,934 | $138,154 | $224,949 |
| Operating Revenue | $113,215 | $61,934 | $138,154 | $224,949 |
| Expenses | ||||
| Interest Expense | $49,933 | $31,080 | $588 | $0 |
| Total Expenses | $592,249 | $757,060 | $930,520 | $1,054,078 |
| Other Income Expense | $72,770 | $-86,943 | $-1,101 | $-1,569,364 |
| Other Non Operating Income Expenses | $6,983 | $4,118 | $4,156 | $16,050 |
| Net Non Operating Interest Income Expense | $-49,933 | $-31,080 | $-585 | $4,716 |
| Interest Expense Non Operating | $49,933 | $31,080 | $588 | $0 |
| Operating Expense | $564,752 | $749,226 | $927,544 | $1,017,124 |
| Other Operating Expenses | $295,877 | $264,591 | $407,849 | $499,702 |
| Selling And Marketing Expense | $3,856 | $14,128 | $19,927 | $33,724 |
| General And Administrative Expense | $250,371 | $458,479 | $427,765 | $392,610 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-456,197 | $-813,149 | $-794,052 | $-2,393,777 |
| Net Interest Income | $-49,933 | $-31,080 | $-585 | $4,716 |
| Normalized Income | $-521,984 | $-722,088 | $-788,795 | $-808,363 |
| Net Income From Continuing And Discontinued Operation | $-456,197 | $-813,149 | $-794,052 | $-2,393,777 |
| Net Income Common Stockholders | $-456,197 | $-813,149 | $-794,052 | $-2,393,777 |
| Net Income | $-456,197 | $-813,149 | $-794,052 | $-2,393,777 |
| Net Income Including Noncontrolling Interests | $-456,197 | $-813,149 | $-794,052 | $-2,393,777 |
| Net Income Continuous Operations | $-456,197 | $-813,149 | $-794,052 | $-2,393,777 |
| Pretax Income | $-456,197 | $-813,149 | $-794,052 | $-2,393,777 |
| Special Income Charges | $0 | $-56,527 | $-1,085 | $-1,583,485 |
| Operating Income | $-479,034 | $-695,126 | $-792,366 | $-829,129 |
| Depreciation Amortization Depletion Income Statement | $2,116 | $3,240 | $6,731 | $8,022 |
| Depreciation And Amortization In Income Statement | $2,116 | $3,240 | $6,731 | $8,022 |
| Depreciation Income Statement | $2,116 | $3,240 | $6,731 | $8,022 |
| Gross Profit | $85,718 | $54,100 | $135,178 | $187,995 |
| Interest Income | - | $0 | $3 | $4,716 |
| Interest Income Non Operating | - | $0 | $3 | $4,716 |
| Per Share | ||||
| Diluted EPS | $-0.01 | $-0.03 | $-0.03 | $-0.08 |
| Basic EPS | $-0.01 | $-0.03 | $-0.03 | $-0.08 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-469,935 | $-687,768 | $-781,476 | $-800,341 |
| Total Unusual Items | $65,787 | $-91,061 | $-5,257 | $-1,585,414 |
| Total Unusual Items Excluding Goodwill | $65,787 | $-91,061 | $-5,257 | $-1,585,414 |
| Reconciled Depreciation | $2,116 | $3,240 | $6,731 | $8,022 |
| EBITDA (Bullshit earnings) | $-404,148 | $-778,829 | $-786,733 | $-2,385,755 |
| EBIT | $-406,264 | $-782,069 | $-793,464 | $-2,393,777 |
| Diluted Average Shares | $34,982,796 | $30,321,336 | $29,374,836 | $29,374,836 |
| Basic Average Shares | $34,982,796 | $30,321,336 | $29,374,836 | $29,374,836 |
| Diluted NI Availto Com Stockholders | $-456,197 | $-813,149 | $-794,052 | $-2,393,777 |
| Write Off | $0 | $72,122 | $1,085 | $841,490 |
| Gain On Sale Of Security | $65,787 | $-34,534 | $-4,172 | $-1,929 |
| Research And Development | $12,532 | $8,788 | $65,272 | $83,066 |
| Selling General And Administration | $254,227 | $472,607 | $447,692 | $426,334 |
| Other Gand A | $246,371 | $410,779 | $419,765 | $384,610 |
| Salaries And Wages | $4,000 | $47,700 | $8,000 | $8,000 |
| Other Special Charges | - | $-15,595 | $-4,156 | - |
| Impairment Of Capital Assets | - | - | $0 | $741,995 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-1,090,423 | $-652,104 | $-82,952 | $706,155 |
| Total Assets | $63,898 | $76,888 | $104,886 | $769,896 |
| Total Non Current Assets | $0 | $2,201 | $5,504 | $11,709 |
| Current Assets | $63,898 | $74,687 | $99,382 | $758,187 |
| Prepaid Assets | $0 | $3,518 | $7,775 | $12,680 |
| Inventory | $28,837 | $17,243 | $2,315 | $4,000 |
| Receivables | $31,749 | $5,077 | $60,391 | $93,946 |
| Taxes Receivable | $6,742 | $2,052 | $6,941 | $14,956 |
| Accounts Receivable | $25,007 | $3,025 | $53,241 | $78,781 |
| Cash Cash Equivalents And Short Term Investments | $3,312 | $48,849 | $28,901 | $647,561 |
| Cash And Cash Equivalents | $3,312 | $48,849 | $28,901 | $647,561 |
| Cash Financial | $3,312 | $48,849 | $28,901 | $647,561 |
| Goodwill And Other Intangible Assets | - | - | - | $0 |
| Debt | ||||
| Net Debt | $265,166 | $143,766 | $12,234 | - |
| Total Debt | $268,478 | $192,615 | $41,135 | - |
| Current Debt And Capital Lease Obligation | $268,478 | $174,348 | $23,072 | - |
| Current Debt | $268,478 | $174,348 | $23,072 | - |
| Other Current Borrowings | $268,478 | $174,348 | $23,072 | - |
| Long Term Debt And Capital Lease Obligation | - | $18,267 | $18,063 | - |
| Long Term Debt | - | $18,267 | $18,063 | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $1,154,321 | $728,992 | $187,838 | $63,741 |
| Total Non Current Liabilities Net Minority Interest | $0 | $18,267 | $18,063 | $0 |
| Current Liabilities | $1,154,321 | $710,725 | $169,775 | $63,741 |
| Other Current Liabilities | $17,788 | $62,525 | - | - |
| Payables And Accrued Expenses | $868,055 | $473,852 | $146,703 | $63,741 |
| Payables | $862,924 | $455,211 | $124,314 | $31,761 |
| Accounts Payable | $130,332 | $56,335 | $23,816 | $23,561 |
| Equity | ||||
| Common Stock Equity | $-1,090,423 | $-652,104 | $-82,952 | $706,155 |
| Total Equity Gross Minority Interest | $-1,090,423 | $-652,104 | $-82,952 | $706,155 |
| Stockholders Equity | $-1,090,423 | $-652,104 | $-82,952 | $706,155 |
| Gains Losses Not Affecting Retained Earnings | $1,434,633 | $1,484,381 | $1,415,181 | $1,410,236 |
| Other Equity Adjustments | $1,434,633 | $1,484,381 | $1,415,181 | $1,410,236 |
| Retained Earnings | $-7,047,937 | $-6,591,740 | $-5,778,591 | $-4,984,539 |
| Other | ||||
| Ordinary Shares Number | $35,244,681 | $33,894,681 | $29,374,836 | $29,374,836 |
| Share Issued | $35,244,681 | $33,894,681 | $29,374,836 | $29,374,836 |
| Tangible Book Value | $-1,090,423 | $-652,104 | $-82,952 | $706,155 |
| Invested Capital | $-821,945 | $-459,489 | $-41,817 | $706,155 |
| Working Capital | $-1,090,423 | $-636,038 | $-70,393 | $694,446 |
| Total Capitalization | $-1,090,423 | $-633,837 | $-64,889 | $706,155 |
| Capital Stock | $4,522,881 | $4,455,255 | $4,280,458 | $4,280,458 |
| Common Stock | $4,522,881 | $4,455,255 | $4,280,458 | $4,280,458 |
| Current Accrued Expenses | $5,131 | $18,641 | $22,389 | $31,980 |
| Dueto Related Parties Current | $732,592 | $398,876 | $100,498 | $8,200 |
| Net PPE | $0 | $2,201 | $5,504 | $11,709 |
| Finished Goods | $24,667 | $17,243 | $0 | $4,000 |
| Raw Materials | $4,170 | $0 | $2,315 | $0 |
| Duefrom Related Parties Current | - | $0 | $209 | $209 |
| Accumulated Depreciation | - | - | $-27,002 | $-18,719 |
| Gross PPE | - | - | $32,506 | $30,428 |
| Machinery Furniture Equipment | - | - | $32,506 | $30,428 |
| Other Short Term Investments | - | - | - | $0 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-178,819 | $-336,023 | $-670,803 | $-885,752 |
| Operating Activities | ||||
| Operating Cash Flow | $-178,819 | $-336,023 | $-670,803 | $-885,752 |
| Cash Flow From Continuing Operating Activities | $-178,819 | $-336,023 | $-674,959 | $-885,752 |
| Operating Gains Losses | $-65,154 | $18,291 | $-6,616 | - |
| Investing Activities | ||||
| Investing Cash Flow | - | - | $0 | $1,157,575 |
| Cash Flow From Continuing Investing Activities | - | - | $0 | $1,157,575 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $67,626 | $200,000 | $20,000 | $0 |
| Financing Cash Flow | $133,282 | $356,157 | $47,242 | $0 |
| Cash Flow From Continuing Financing Activities | $133,282 | $356,157 | $47,242 | $0 |
| Net Common Stock Issuance | $67,626 | $200,000 | $20,000 | $0 |
| Common Stock Issuance | $67,626 | $200,000 | $20,000 | $0 |
| Net Other Financing Charges | - | $-16,000 | - | - |
| Other | ||||
| Repayment Of Debt | $0 | $-10,000 | $0 | $0 |
| Issuance Of Debt | $65,656 | $182,157 | $27,242 | $0 |
| End Cash Position | $3,312 | $48,849 | $28,901 | $647,561 |
| Beginning Cash Position | $48,849 | $28,901 | $647,561 | $380,621 |
| Effect Of Exchange Rate Changes | $0 | $-186 | $4,901 | $-4,883 |
| Changes In Cash | $-45,537 | $20,134 | $-623,561 | $271,823 |
| Net Issuance Payments Of Debt | $65,656 | $172,157 | $27,242 | $0 |
| Net Short Term Debt Issuance | $65,656 | $182,157 | $27,242 | $0 |
| Short Term Debt Issuance | $65,656 | $182,157 | $27,242 | $0 |
| Net Long Term Debt Issuance | $0 | $-10,000 | $27,242 | $0 |
| Long Term Debt Payments | $0 | $-10,000 | $0 | - |
| Change In Working Capital | $318,793 | $319,568 | $121,772 | $-83,482 |
| Change In Payables And Accrued Expense | $353,541 | $346,151 | $79,631 | $-79,532 |
| Change In Prepaid Assets | $3,518 | $4,257 | $5,169 | $2,598 |
| Change In Inventory | $-11,594 | $-25,763 | $813 | $37,464 |
| Change In Receivables | $-26,672 | $-5,077 | $36,159 | $-44,012 |
| Other Non Cash Items | $21,623 | $26,205 | $277 | - |
| Stock Based Compensation | $0 | $37,700 | $0 | $0 |
| Asset Impairment Charge | $0 | $72,122 | $1,085 | $1,583,485 |
| Depreciation Amortization Depletion | $2,116 | $3,240 | $6,731 | $8,022 |
| Depreciation And Amortization | $2,116 | $3,240 | $6,731 | $8,022 |
| Depreciation | $2,116 | $3,240 | $6,731 | $8,022 |
| Gain Loss On Investment Securities | $-66,053 | $34,877 | - | - |
| Net Foreign Currency Exchange Gain Loss | $899 | $-991 | $-2,460 | $0 |
| Net Income From Continuing Operations | $-456,197 | $-813,149 | $-794,052 | $-2,393,777 |
| Long Term Debt Issuance | - | $182,157 | $27,242 | $0 |
| Net Investment Purchase And Sale | - | - | $0 | $1,157,575 |
| Proceeds From Stock Option Exercised | - | - | - | $0 |
| Short Term Debt Payments | - | - | - | $0 |
| Net Intangibles Purchase And Sale | - | - | - | $0 |
| Purchase Of Intangibles | - | - | - | $0 |
| Change In Payable | - | - | - | $-79,532 |
| Change In Account Payable | - | - | - | $-79,532 |
Fetched: 2026-02-02